Compound ID | 1211
| Details of activity: | TLR4 inhibitor |
| Institute where first reported: | Daiichi Sankyo |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Phase 1 |
| Development status: | Inactive |
| External links: | |
| Citation: | http://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-121939 |